Dai-ichi Karkari (526821)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarterly sales of ₹38 Cr show the company still has operating scale in specialty chemicals.
• Annual ROE and ROCE are positive at 3.31% and 4.29%, though low.
• Dividend yield of 1.38% provides some return to shareholders.
• Stock is trading at the top of its 52-week range, indicating strong market interest.

Concerns

• Profit growth is -144.90% and the latest quarter reported a net loss of ₹1 Cr.
• Sales declined by 7.12%, showing weak demand or pricing power.
• P/E of 33.85 and P/B of 3.34 are far above what the underlying returns justify.
• Piotroski F-Score of 3/9 and FairStock Score of 0/100 point to poor financial health.

AI Analysis

When I look at Dai-ichi Karkari, I ask first: is this a wonderful business? The numbers say no. Sales have shrunk by 7.12%, profits have collapsed by 144.90%, and the latest quarter still shows a loss of ₹1 crore on sales of ₹38 crore. The Piotroski F-score of 3/9 reinforces my suspicion: this is a company with deteriorating fundamentals, not one building financial strength. The return on equity is 3.31%, and return on capital employed is only 4.29%. I can earn more than that in a fixed deposit without taking business risk. Yet Mr. Market is asking ₹741.50 per share, or 33.85 times earnings, and 3.34 times book value of ₹221.97. That offers no margin of safety. In Graham's language, paying up for mediocre returns is speculation, not investment. The stock has moved from ₹219 to ₹741.50 over the year, but price performance without underlying earnings improvement is dangerous. I would note that the company still pays a dividend yield of 1.38% and generates some scale in specialty chemicals, but a dividend is only safe if earnings support it. With profit growth deeply negative and the FairStock score at 0/100, the balance of evidence is decidedly risky. Can this be a turnaround? Possibly, but I cannot invest on possibilities. I need proof: stabilised sales, positive quarterly net profit, and returns moving above the cost of capital. Until then, the only rational action for a value investor is to pass. I'd rather miss a rally than overpay for a business whose economics and fundamentals are going in the wrong direction.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer